M. Angela Cenci Basal Ganglia Pathophysiology Unit, Dept. Experimental Medical Science Lund University Biography Publications Institution JoVE Articles M. Angela Cenci has not added a biography. If you are M. Angela Cenci and would like to personalize this page please email our Author Liaison for assistance. Publications Reply To: Letter to Editor by Chaudhuri, Jenner, Antonini Movement Disorders : Official Journal of the Movement Disorder Society. May, 2020 | Pubmed ID: 32415716 Preface: The Evolving Scenario of Parkinson's Research Progress in Brain Research. 2020 | Pubmed ID: 32247377 Animal Models for Preclinical Parkinson's Research: An Update and Critical Appraisal Progress in Brain Research. 2020 | Pubmed ID: 32247366 The Role of Glia in Parkinson's Disease: Emerging Concepts and Therapeutic Applications Progress in Brain Research. 2020 | Pubmed ID: 32247363 D1-mGlu5 Heteromers Mediate Noncanonical Dopamine Signaling in Parkinson's Disease The Journal of Clinical Investigation. Mar, 2020 | Pubmed ID: 32039920 Dyskinesia Matters Movement Disorders : Official Journal of the Movement Disorder Society. Mar, 2020 | Pubmed ID: 31872501 Seeding of Protein Aggregation Causes Cognitive Impairment in Rat Model of Cortical Synucleinopathy Movement Disorders : Official Journal of the Movement Disorder Society. 11, 2019 | Pubmed ID: 31449702 Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 04, 2019 | Pubmed ID: 30756361 Significance and Translational Value of High-Frequency Cortico-Basal Ganglia Oscillations in Parkinson's Disease Journal of Parkinson's Disease. 2019 | Pubmed ID: 30594935 Striatonigral Neurons Divide into Two Distinct Morphological-physiological Phenotypes After Chronic L-DOPA Treatment in Parkinsonian Rats Scientific Reports. 07, 2018 | Pubmed ID: 29968767 On the Neuronal Circuitry Mediating L-DOPA-induced Dyskinesia Journal of Neural Transmission (Vienna, Austria : 1996). 08, 2018 | Pubmed ID: 29704061 MGlu Receptors in the Treatment of Parkinson's Disease and L-DOPA-induced Dyskinesia Current Opinion in Pharmacology. 02, 2018 | Pubmed ID: 29625424 Animal Models of L-dopa-induced Dyskinesia in Parkinson's Disease Movement Disorders : Official Journal of the Movement Disorder Society. 07, 2018 | Pubmed ID: 29488257 Levodopa-induced Abnormal Involuntary Movements Correlate with Altered Permeability of the Blood-brain-barrier in the Basal Ganglia Scientific Reports. 11, 2017 | Pubmed ID: 29167476 Translating Scientific Advances into Disease-modifying Therapies for Parkinson's Disease Experimental Neurology. 12, 2017 | Pubmed ID: 29145992 CK2 Oppositely Modulates L-DOPA-Induced Dyskinesia Via Striatal Projection Neurons Expressing D1 or D2 Receptors The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 12, 2017 | Pubmed ID: 29097596 Neuroprotection and Neurorestoration As Experimental Therapeutics for Parkinson's Disease Experimental Neurology. 12, 2017 | Pubmed ID: 28988910 Differential Effects of Gaseous Versus Injectable Anesthetics on Changes in Regional Cerebral Blood Flow and Metabolism Induced by L-DOPA in a Rat Model of Parkinson's Disease Experimental Neurology. 06, 2017 | Pubmed ID: 28284817 Validation of an Improved Scale for Rating L-DOPA-induced Dyskinesia in the Mouse and Effects of Specific Dopamine Receptor Antagonists Neurobiology of Disease. Dec, 2016 | Pubmed ID: 27597526 Dissociation of Metabolic and Hemodynamic Levodopa Responses in the 6-hydroxydopamine Rat Model Neurobiology of Disease. Dec, 2016 | Pubmed ID: 27544483 Dramatic Differences in Susceptibility to L-DOPA-induced Dyskinesia Between Mice That Are Aged Before or After a Nigrostriatal Dopamine Lesion Neurobiology of Disease. Oct, 2016 | Pubmed ID: 27312773 Gene Therapy Blockade of Dorsal Striatal P11 Improves Motor Function and Dyskinesia in Parkinsonian Mice Proceedings of the National Academy of Sciences of the United States of America. Feb, 2016 | Pubmed ID: 26787858 On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats Movement Disorders : Official Journal of the Movement Disorder Society. Jan, 2016 | Pubmed ID: 26749366 M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia Neuron. Nov, 2015 | Pubmed ID: 26590347 Increased CSF Biomarkers of Angiogenesis in Parkinson Disease Neurology. Nov, 2015 | Pubmed ID: 26511451 Rodent Models of Impulsive-compulsive Behaviors in Parkinson's Disease: How Far Have We Reached? Neurobiology of Disease. Oct, 2015 | Pubmed ID: 26325219 Zooming in on the Small: the Plasticity of Striatal Dendritic Spines in L-DOPA-induced Dyskinesia Movement Disorders : Official Journal of the Movement Disorder Society. Apr, 2015 | Pubmed ID: 25759263 Pharmacological Stimulation of Metabotropic Glutamate Receptor Type 4 in a Rat Model of Parkinson's Disease and L-DOPA-induced Dyskinesia: Comparison Between a Positive Allosteric Modulator and an Orthosteric Agonist Neuropharmacology. Aug, 2015 | Pubmed ID: 25749357 Activity of Serotonin 5-HT(1A) Receptor 'biased Agonists' in Rat Models of Parkinson's Disease and L-DOPA-induced Dyskinesia Neuropharmacology. Jun, 2015 | Pubmed ID: 25645393 A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine Molecular Neurobiology. Dec, 2015 | Pubmed ID: 25307288 Presynaptic Mechanisms of L-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications Frontiers in Neurology. 2014 | Pubmed ID: 25566170 Cell Type-specific Plasticity of Striatal Projection Neurons in Parkinsonism and L-DOPA-induced Dyskinesia Nature Communications. Oct, 2014 | Pubmed ID: 25360704 Pharmacological Stimulation of Sigma-1 Receptors Has Neurorestorative Effects in Experimental Parkinsonism Brain : a Journal of Neurology. Jul, 2014 | Pubmed ID: 24755275 Mechanisms of Dopamine D1 Receptor-mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5 The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Mar, 2014 | Pubmed ID: 24672017 Glutamatergic Pathways As a Target for the Treatment of Dyskinesias in Parkinson's Disease Biochemical Society Transactions. Apr, 2014 | Pubmed ID: 24646284 Molecular Adaptations of Striatal Spiny Projection Neurons During Levodopa-induced Dyskinesia Proceedings of the National Academy of Sciences of the United States of America. Mar, 2014 | Pubmed ID: 24599591 Investigating the Molecular Mechanisms of L-DOPA-induced Dyskinesia in the Mouse Parkinsonism & Related Disorders. Jan, 2014 | Pubmed ID: 24262181 Region-specific Restoration of Striatal Synaptic Plasticity by Dopamine Grafts in Experimental Parkinsonism Proceedings of the National Academy of Sciences of the United States of America. Nov, 2013 | Pubmed ID: 24170862 Modulating MGluR5 and 5-HT1A/1B Receptors to Treat L-DOPA-induced Dyskinesia: Effects of Combined Treatment and Possible Mechanisms of Action Experimental Neurology. Dec, 2013 | Pubmed ID: 24029003 Bad News for Neuroprotective Therapies in PD? Journal of Parkinson's Disease. Jan, 2013 | Pubmed ID: 24018335 A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation Journal of Parkinson's Disease. 2012 | Pubmed ID: 23938263 Levodopa-induced Dyskinesia is Strongly Associated with Resonant Cortical Oscillations The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Nov, 2012 | Pubmed ID: 23175810 Impact of L-DOPA Treatment on Regional Cerebral Blood Flow and Metabolism in the Basal Ganglia in a Rat Model of Parkinson's Disease NeuroImage. May, 2012 | Pubmed ID: 22406356 Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease CNS & Neurological Disorders Drug Targets. Sep, 2011 | Pubmed ID: 21838677 Vascular Endothelial Growth Factor is Upregulated by L-dopa in the Parkinsonian Brain: Implications for the Development of Dyskinesia Brain : a Journal of Neurology. Aug, 2011 | Pubmed ID: 21771855 Impact of the Lesion Procedure on the Profiles of Motor Impairment and Molecular Responsiveness to L-DOPA in the 6-hydroxydopamine Mouse Model of Parkinson's Disease Neurobiology of Disease. Jun, 2011 | Pubmed ID: 21310234 Inhibition of Ras-guanine Nucleotide-releasing Factor 1 (Ras-GRF1) Signaling in the Striatum Reverts Motor Symptoms Associated with L-dopa-induced Dyskinesia Proceedings of the National Academy of Sciences of the United States of America. Dec, 2010 | Pubmed ID: 21115823 Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-induced Dyskinesia Annals of Neurology. Nov, 2010 | Pubmed ID: 20882603 Maladaptive Striatal Plasticity in L-DOPA-induced Dyskinesia Progress in Brain Research. 2010 | Pubmed ID: 20696322 A MGluR5 Antagonist Under Clinical Development Improves L-DOPA-induced Dyskinesia in Parkinsonian Rats and Monkeys Neurobiology of Disease. Sep, 2010 | Pubmed ID: 20452425 L-DOPA-induced Dopamine Efflux in the Striatum and the Substantia Nigra in a Rat Model of Parkinson's Disease: Temporal and Quantitative Relationship to the Expression of Dyskinesia Journal of Neurochemistry. Mar, 2010 | Pubmed ID: 20050978 Rodent Models of Treatment-induced Motor Complications in Parkinson's Disease Parkinsonism & Related Disorders. Dec, 2009 | Pubmed ID: 20123549 Plastic Effects of L-DOPA Treatment in the Basal Ganglia and Their Relevance to the Development of Dyskinesia Parkinsonism & Related Disorders. Dec, 2009 | Pubmed ID: 20083009 Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-induced Angiogenic Activity in a Rat Model of Parkinson's Disease Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Nov, 2009 | Pubmed ID: 19606087 Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling The Journal of Pharmacology and Experimental Therapeutics. Jul, 2009 | Pubmed ID: 19357321 Ratings of L-DOPA-induced Dyskinesia in the Unilateral 6-OHDA Lesion Model of Parkinson's Disease in Rats and Mice Current Protocols in Neuroscience. Oct, 2007 | Pubmed ID: 18428668 L-DOPA-induced Dyskinesia: Cellular Mechanisms and Approaches to Treatment Parkinsonism & Related Disorders. 2007 | Pubmed ID: 18267248 Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA-induced Dyskinesia and the Role of Dopamine D1 Receptors Biological Psychiatry. Oct, 2007 | Pubmed ID: 17662258 Dopamine Dysregulation of Movement Control in L-DOPA-induced Dyskinesia Trends in Neurosciences. May, 2007 | Pubmed ID: 17400300 Antagonism of Metabotropic Glutamate Receptor Type 5 Attenuates L-DOPA-induced Dyskinesia and Its Molecular and Neurochemical Correlates in a Rat Model of Parkinson's Disease Journal of Neurochemistry. Apr, 2007 | Pubmed ID: 17359492 The "motor Complication Syndrome" in Rats with 6-OHDA Lesions Treated Chronically with L-DOPA: Relation to Dose and Route of Administration Behavioural Brain Research. Feb, 2007 | Pubmed ID: 17157933 Endothelial Proliferation and Increased Blood-brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-dihydroxyphenyl-L-alanine-induced Dyskinesia The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Sep, 2006 | Pubmed ID: 16971529 Post- Versus Presynaptic Plasticity in L-DOPA-induced Dyskinesia Journal of Neurochemistry. Oct, 2006 | Pubmed ID: 16942598 Graft Placement and Uneven Pattern of Reinnervation in the Striatum is Important for Development of Graft-induced Dyskinesia Neurobiology of Disease. Mar, 2006 | Pubmed ID: 16256359 Dyskinesias and Dopamine Cell Replacement in Parkinson's Disease: a Clinical Perspective Brain Research Bulletin. Dec, 2005 | Pubmed ID: 16324999 L-DOPA-induced Dyskinesia in the Intrastriatal 6-hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function Neurobiology of Disease. Jul, 2002 | Pubmed ID: 12127155 Pharmacological Validation of Behavioural Measures of Akinesia and Dyskinesia in a Rat Model of Parkinson's Disease The European Journal of Neuroscience. Jan, 2002 | Pubmed ID: 11860512 CAMP Response Element-binding Protein is Required for Dopamine-dependent Gene Expression in the Intact but Not the Dopamine-denervated Striatum The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Dec, 2001 | Pubmed ID: 11739600 多目的な自家製ビデオカメラとDeepLabCutを使用して、オペラコンディショニングチャンバー内のラットを追跡する Erik K. H. Clemensson1, Morteza Abbaszadeh1, Silvia Fanni1, Elena Espa1, M. Angela Cenci1 1Basal Ganglia Pathophysiology Unit, Dept. Experimental Medical Science, Lund University JoVE 61409 Comportamiento
多目的な自家製ビデオカメラとDeepLabCutを使用して、オペラコンディショニングチャンバー内のラットを追跡する Erik K. H. Clemensson1, Morteza Abbaszadeh1, Silvia Fanni1, Elena Espa1, M. Angela Cenci1 1Basal Ganglia Pathophysiology Unit, Dept. Experimental Medical Science, Lund University JoVE 61409 Comportamiento